e-learning
resources
Vienna 2012
Monday, 03.09.2012
New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Response to Mtb Rv2628 latency antigen associates with bacterial containment
L. Petrone, V. Vanini, E. Petruccioli, T. Chiacchio, G. Cuzzi, K. L. M. C. Franken, F. N. Lauria, E. Girardi, T. H. M. Ottenhoff, D. Goletti (Rome, Italy; Leiden, Netherlands)
Source:
Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection
Session:
New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection
Session type:
Oral Presentation
Number:
1876
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Petrone, V. Vanini, E. Petruccioli, T. Chiacchio, G. Cuzzi, K. L. M. C. Franken, F. N. Lauria, E. Girardi, T. H. M. Ottenhoff, D. Goletti (Rome, Italy; Leiden, Netherlands). Response to Mtb Rv2628 latency antigen associates with bacterial containment. Eur Respir J 2012; 40: Suppl. 56, 1876
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
ERS short guidelines on COVID-19 management
Influenza vaccination: protecting the most vulnerable
Understanding new vaccines for SARS-CoV-2 and their regulation
Related content which might interest you:
Humoral immune response against 38-kDa and 16-kDa mycobacterial antigens in tuberculosis
Source: Eur Respir J 2007; 29: 143-148
Year: 2007
Quantitative T-cell interferon-gamma responses to
Mycobacterium tuberculosis
-specific antigens in latent and active tuberculosis
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008
In vitro
immune response to
Mycobacterium tuberculosis
antigens
Source: Eur Respir J 2005; 26: Suppl. 49, 22s
Year: 2005
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection
Source: Eur Respir J 2010; 35: 619-626
Year: 2010
Tuberculosis treatment effect on T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens
Source: Eur Respir J 2010; 36: 355
Year: 2010
ESAT-6/CFP-10 and PPD-stimulated cytokine production in patients with MTB infection
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease
Year: 2007
IGG immune response against MPT-64, CFP-10 and ESAT-6 antigens in children with pulmonary tuberculosis
Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection
Year: 2009
IL-2 memory response after specific in vitro stimulation associates to latent tuberculosis infection
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009
Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
Antigen specific CD4 and CD8 signatures of different Mycobacterium tuberculosis (MTB) infection phases
Source: Annual Congress 2010 - Tuberculosis: from bench to bedside
Year: 2010
Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection
Source: Eur Respir J 2010; 36: 135-142
Year: 2010
Monitoring of ESAT-6/CFP-10 selected peptides response during prophylaxis in individuals exposed to
M. tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 363s
Year: 2006
New tools to discriminate active from past tuberculosis: comparison of the response to RD1 antigens vs latency antigens
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009
Design of immunogenic multiepitopic
mycobacterium tuberculosis
peptides from genes selected using
in vitro
models of mycobacterial macrophage infection
Source: Eur Respir J 2007; 30: Suppl. 51, 493s
Year: 2007
Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test
Source: Eur Respir J 2006; 28: 16-23
Year: 2006
Massive expansion of PPD-reactive CD4 T cells directed against a single peptide epitope from the
M. tuberculosis
ESAT-6 protein
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT)
Source: Eur Respir J 2001; 18: Suppl. 33, 307s
Year: 2001
Characterization of the HBHA response in TB patients with or without HIV infection.
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
IL-4 subverts mycobacterial containment in
Mycobacterium tuberculosis
-infected human macrophages
Source: Eur Respir J, 54 (2) 1802242; 10.1183/13993003.02242-2018
Year: 2019
QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens
Source: Eur Respir J 2016; 47: 660-664
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept